A robust quarter, despite Corona Q1 2020 telephone press conference

May 6, 2020

Safe-harbor statement

The disclosures in this presentation are for information purposes only and do not constitute an offer to sell or an invitation

to submit an offer to buy LANXESS AG securities. There is no public market for the trade of LANXESS AG securities in

the U.S.

This presentation contains certain forward-looking statements, including assumptions, opinions, expectations and views

of the company as well as assumptions and opinions cited from third-party sources. Various known and unknown risks,

uncertainties and other factors could cause the actual results, financial position, development or performance of

LANXESS AG to differ materially from the estimates expressed or implied herein. LANXESS AG does not guarantee that

the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility

for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast

developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on,

any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any

errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its

affiliated companies or any of such person’s officers, directors or employees accept any liability whatsoever arising

directly or indirectly from the use of this document.

Well prepared through the crisis

Protection of employees of utmost priority

Liquidity secured

3

Production plants running

Two out of four segments with positive earnings development

Q1 '19 Q1 '20 Q1 '19 Q1 '20

1,738 1,704 15.7 % 14.4 %

Balanced portfolio mitigates Corona effects

Net income Sales EBITDA EBITDA margin

All figures in EUR million

All EBITDA figures are pre exceptionals

Net income from continuing operations

4

272 245

Q1 '19 Q1 '20

87

63

Q1 '19 Q1 '20

-28% -2% -10% -1.3%p

First report with new segment structure

Engineering Materials Advanced

Intermediates Specialty Additives

Advanced Industrial

Intermediates

Lubricant Additives

Business

Polymer Additives

Material Protection

Products

Rhein Chemie Liquid Purification

Technologies

Saltigo

High Performance

Materials

Urethane Systems Inorganic Pigments

Consumer Protection

5

Advanced Intermediates: Weaker demand for

intermediates, especially in Asia

584 558

Q1 '19 Q1 '20

105

88

Q1 '19 Q1 '20

Sales EBITDA

Sales and EBITDA in EUR million

All EBITDA figures are pre exceptionals 6

-4% -16%

Specialty Additives: Strong bromine business

balances Corona effects

485 499

Q1 '19 Q1 '20

83 85

Q1 '19 Q1 '20

Sales EBITDA

Sales and EBITDA in EUR million

All EBITDA figures are pre exceptionals 7

+3% +2%

60

67

Q1 '19 Q1 '20

Consumer Protection: Disinfectants and

agro chemicals drive sales and earnings

264 279

Q1 '19 Q1 '20

Sales EBITDA

Sales and EBITDA in EUR million

All EBITDA figures are pre exceptionals 8

+6% +12%

Helping in times of crisis: LANXESS donates

disinfectants worldwide

9

Rely+On Virkon effective against

coronavirus

Used for surface disinfection

Donation sufficient for 1 million

liters of disinfectant solution

Recipients: Hospitals and other

public institutions in 13 severely

affected countries

Engineering Materials: Weak auto market

burdens earnings

382 347

Q1 '19 Q1 '20

65

49

Q1 '19 Q1 '20

Sales EBITDA

Sales and EBITDA in EUR million

All EBITDA figures are pre exceptionals 10

-9% -25%

Corona update

Worldwide 31 confirmed cases of COVID-19 at

LANXESS, 27 of them already recovered

All plants in operation worldwide

Temporary shutdowns in China, Italy, India and

Argentina in the meantime being basically reversed

Logistics and raw material supply with delays, but

generally functioning

Office operations in Germany are resuming gradually

since May 4

German sites: Short-time working currently at three

plants (Bitterfeld, Brilon, Leverkusen)

11

Liquidity secured

Financial crisis Crisis 2012/2013 Corona crisis

Cash Financial assets Share buy-back suspended

Revolving credit facility

drawn down

Sale of Currenta stake closed

(ca. EUR 930 million*)

Capex projects reviewed and

postponed(ca. EUR 50 million)

Cost containment measures

(ca. EUR 50-100 million)

Compensation for Supervisory

Board, Board of Management and

top management reduced

Liquidity of LANXESS in times of crises (in EUR million) Measures

* pre tax 12

~ 300

< 1,000

~3,000

Occupational safety has utmost priority

Switch to fever scans at site entrances

Temprary changeover to 12-hour shifts

Contact-free shift handover

Compulsory use of masks in production and

administration

Extension of IT resources to improve

working from home

Daily liquidity status

Financial scenario modeling

Close supply chain monitoring

Board meetings almost daily

Measures for better infection prevention Comprehensive crisis scenario reporting

13

Outlook: Guidance adjusted due to Corona effects

Continuing corona pandemic dominates economic

development

Burden of COVID-19 to accelerate in Q2 and Q3

Disruptions of supply chains and logistics cannot be

excluded

Market development

Forecast for Q2 2020:

EBITDA at EUR 200-250 million

Forecast for full year 2020:

EBITDA at EUR 800-900 million

LANXESS

All EBITDA figures are pre exceptionals 14